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Abstract 21 
Aims: The economic burden of endometriosis and pelvic pain involves direct and indirect 22 
healthcare costs due to work loss and decreased productivity. However, the relation between 23 
endometriosis, pelvic pain, and employment remains underinvestigated. This study aimed at 24 
providing preliminary insights into this topic. Methods: We compared employment status (having 25 
vs not having a job) in 298 consecutive endometriosis patients and in 332 women without a history 26 
of endometriosis (control group). We also examined the association between pelvic pain and 27 
employment status. Results: Women with endometriosis were less likely to be employed compared 28 
to women without endometriosis (odds ratio =.508; 95% CI =.284-.908; P = .022). Women with 29 
symptomatic endometriosis were less likely to be employed relative to controls (odds ratio =.345; 30 
95% CI =.184-.650; P = .001), as well as to asymptomatic endometriosis patients (odds ratio 31 
=.362; 95% CI =.167-.785; P = .01). No significant differences emerged between asymptomatic 32 
endometriosis and the control group (P > .05). Greater severity of dysmenorrhea, dyspareunia, 33 
chronic pelvic pain, and dyschezia was found in unemployed endometriosis patients (vs employed 34 
endometriosis participants). Conclusion: Endometriosis symptoms may significantly affect 35 
women’s professional life, with important socioeconomic, legal, and political implications. 36 
Community-based participatory research is encouraged. 37 
 38 
KEYWORDS: Endometriosis, pelvic pain, employment, endometriosis symptoms, impact of 39 
endometriosis  40 
   41 
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Introduction 42 
As a chronic gynecological condition often associated with pelvic pain—either cyclic and 43 
temporary (such as dysmenorrhea, dyspareunia, and dyschezia), or chronic [1,2]—endometriosis 44 
negatively affects women’s quality of life and psychological health [3-5]. Painful endometriosis 45 
involves remarkable limitations in everyday activities, including education and work [6-8]. This is a 46 
major problem if one considers that endometriosis mostly affects women in the reproductive period, 47 
with the greatest risk among women aged 25-35 [9]. In a survey with 107 Puerto Rican women 48 
diagnosed with endometriosis [10], 66% reported physical limitations affecting their working 49 
capacity, with an overall noticeable decrease in the quality of their work (85%), to the point of not 50 
being able to work because of pain (20%); 69% of patients reported that they continued working 51 
despite pain, which may also lead to reduced productivity at work—a phenomenon referred to as 52 
presenteeism [11].      53 
The disruptive impact of endometriosis on women’s lives and plans for the future raises 54 
concerns not only for its negative consequences on women’s psychological and physical wellbeing 55 
[8], but also for the economic costs of the disease to patients, employers, and society [12-14]. In a 56 
retrospective cohort study, Soliman et al. [15] found that women with endometriosis had 57 
significantly higher direct healthcare costs, as well as indirect costs due to work loss through 58 
absenteeism and short-/long-term disability relative to control participants without a history of 59 
endometriosis. As underlined by Hummelshoj [16], treatment costs account for only one third of the 60 
total annual economic burden of endometriosis (estimated at €9579 per woman [11]), because two 61 
thirds of this cost is caused by productivity loss due to pain symptoms [11,17]).    62 
Although these findings suggest that endometriosis, especially when painful, causes 63 
remarkable economic costs not only to the women affected, but also to the healthcare system and 64 
society, there is a paucity of research on the extent to which endometriosis and its pain symptoms 65 
affect women’s professional life, especially in the Italian context.     66 
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Given this scenario, we conducted the current study to provide preliminary insights into the 67 
relation between endometriosis, pelvic pain, and employment status (having vs not having a job).  68 
Our hypotheses were that: (1) endometriosis participants would have lower probability of having a 69 
job compared to women without a history of endometriosis (control group); (2) symptomatic (ie, 70 
painful) endometriosis involves decreased probability of being employed compared to 71 
asymptomatic endometriosis and the control group. In order to provide further evidence to this 72 
second hypothesis, we also compared the severity of pelvic pain (dysmenorrhea, dyspareunia, 73 
dyschezia, and chronic pelvic pain) in endometriosis patients without an occupation vs employed 74 
endometriosis participants. 75 
 76 
Material and methods 77 
This article presents findings from secondary analyses of data derived from two broader research 78 
projects on the psychological impact of endometriosis approved by the competent Institutional 79 
Review Board (Milan Ethics Committee, Area B, project 1: determination #275/2013, approval date 80 
February 12, 2013; project 2: determination #1018/2016, approval date May 24, 2016). Data were 81 
collected between 2013 and 2017 in a tertiary endometriosis referral center located in an academic 82 
hospital in Northern Italy. In this study we considered data reported by 630 consecutively recruited 83 
women aged 25-45 years. Young women aged 18-24 were not included in these analyses because 84 
most of them were high school or university students and overall did not represent the typical Italian 85 
working-age female population. Students aged ≥ 25 were excluded from this study, whose specific 86 
focus was the relation between endometriosis and employment status.  87 
Of the 630 total participants, all of whom had signed a written informed consent form prior 88 
to recruitment, 298 were endometriosis patients, of which 290 with surgical diagnosis and 8 with 89 
current non-surgical diagnosis (for further information regarding the reliability of non-surgical 90 
diagnosis of endometriosis see Nisenblat et al. [18]; Somigliana et al. [19]; Vercellini et al. [20]; see 91 
also Facchin et al. [7]). The other 332 participants were women without a history of endometriosis 92 
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attending our hospital for routine gynecological visits (including cervical cancer screening program 93 
and contraception). Exclusion criteria were: uterine fibroids malignancy; sexually transmitted, 94 
urologic, rheumatologic, autoimmune, coronary, hepatic, or renal diseases; hypertension; diabetes; 95 
diagnosed mental illness.  96 
In this study, our main variables of interest were employment status and pelvic pain severity. 97 
All participants provided demographic information, including employment status (“Are you 98 
currently employed?”; dichotomous variable coded “Yes”/ “No”). Women with endometriosis rated 99 
on a 0 (no pain at all) – 10 (the worst imaginable pain) Numerical Rating Scale (NRS) the severity 100 
of four types of pelvic pain: dysmenorrhea, dyspareunia, chronic pelvic pain, and dyschezia. Of the 101 
298 endometriosis participants, those who reported NRS scores > 5 for at least one of these four 102 
types of pelvic pain were assigned to the symptomatic endometriosis subgroup, while the remaining 103 
were included into the asymptomatic endometriosis subgroup.   104 
Statistical analyses were conducted with SPSS (Statistical Package for Social Sciences, 105 
SPSS Inc., 162 Chicago, IL, USA) software version 17. A three-step analytic approach was used to 106 
test our hypotheses. First, a binary logistic regression was conducted to generally determine the 107 
likelihood of having a job (dependent variable) in the endometriosis group (overall) vs the control 108 
condition, controlling for demographic factors (age, level of education, marital status, having vs not 109 
having children). Second, we performed two hierarchical binary logistic regressions to compare 110 
employment status in the two endometriosis subgroups (symptomatic and asymptomatic) and the 111 
control group, controlling for the effects of demographic factors (these potential confounders were 112 
entered in block 1 in all the regressions conducted). Reference groups were the control condition in 113 
the first regression, and asymptomatic endometriosis in the second regression, such that all the 114 
possible between-group comparisons were performed. Third, a multivariate analysis of covariance 115 
(MANCOVA) controlling for age was conducted only on the endometriosis group to evaluate 116 
pelvic pain severity (dysmenorrhea, dyspareunia, chronic pelvic pain, and dyschezia) in employed 117 
vs unemployed women with endometriosis. Significance tests were performed at P < .05.   118 
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Results  119 
The mean ± standard deviation age of the 630 participants was 35.3 ± 5.7. The majority of women 120 
had an occupation (568 [90%]), went to university (346 [55%]), were unmarried (379 [60%]), and 121 
did not have children (440 [70%]). The endometriosis group included 188 patients (63%) with 122 
ovarian endometriomas, 79 (27%) with rectovaginal nodules, 11 (4%) with deep lesions infiltrating 123 
the pouch of Douglas and parametria, 10 (3%) with peritoneal endometriosis, 7 (2%) with bladder 124 
endometriosis, and 3 (1%) with bowel endometriosis. As regards hormonal treatment, 161 (54%) 125 
endometriosis participants were under therapy. 126 
Of the total 298 endometriosis patients, 154 (52%) reported NRS scores > 5 for at least one 127 
of the four types of pelvic pain considered in this study and were included in the symptomatic 128 
endometriosis subgroup, while the remaining 144 (48%) patients were assigned to the 129 
asymptomatic endometriosis subgroup. Demographic characteristics by study group and the 130 
severity of endometriosis-related pelvic pain symptoms are reported in Table 1.    131 
The first binary logistic regression conducted revealed that women with endometriosis were 132 
less likely to have a job compared to the control group (odds ratio =.508; 95% CI =.284-.908; P = 133 
.022). Secondly, we found that women with symptomatic endometriosis were less likely to be 134 
employed compared not only to control participants (odds ratio =.345; 95% CI =.184-.650; P = 135 
.001), but also to asymptomatic endometriosis patients (odds ratio =.362; 95% CI =.167-.785; P = 136 
.01), while no significant differences were found between asymptomatic endometriosis and the 137 
control group (P > .05).  138 
A third set of analyses examined the association between pelvic pain symptoms and 139 
employment status using MANCOVA. Among women with endometriosis, those who did not have 140 
a job reported greater dysmenorrhea (F[1,294] = 4.45; P = .036), dyspareunia (F[1,294] = 5.09; P 141 
= .025), dyschezia (F[1,294] = 6.59; P = .011), and chronic pelvic pain (F[1,294] = 5.54; P = 142 
.019). 143 
 144 
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Discussion  145 
In our study, aimed at exploring the relation between endometriosis, pelvic pain symptoms, 146 
and employment status, women with endometriosis had lower probability of having a job relative to 147 
women without a history of endometriosis. The fact that endometriosis has a negative impact on 148 
women’s professional life is neither new, nor surprising [3,4,6]. A recent review of the literature 149 
[21] highlighted that the economic burden of endometriosis is associated with both direct costs 150 
(inpatient and outpatient costs, pharmacological treatments, and other healthcare services) and 151 
indirect costs due to decreased work productivity, sick leave and time off to attend medical 152 
appointments, or even loss of employment, although with great worldwide variations (see also 22-153 
25). Of the 12 studies included in this 2016 review by Soliman et al. [21], only one [26] was 154 
conducted in Italy and reported drug regimen costs per patient per six months, while a 10-country 155 
study by Nnoaham et al [17] showed that Italian endometriosis patients reported the highest 156 
absenteeism-related costs (US$231/wk) and the second highest presenteeism costs (around 157 
US$230/wk) after the USA. 158 
However, our Italian study may fill a gap in the endometriosis research literature by 159 
highlighting the effects of endometriosis-related pelvic pain symptoms (dysmenorrhea, dyspareunia, 160 
dyschezia, and chronic pelvic pain) on a ‘hard’ dichotomous outcome (having vs not having a job). 161 
In fact, our endometriosis participants with symptomatic, painful endometriosis had decreased 162 
probability of being employed compared with asymptomatic endometriosis patients and control 163 
participants, while no significant differences were found between asymptomatic endometriosis and 164 
the control group. Moreover, higher pain severity on all four types of pelvic pain was found among 165 
unemployed endometriosis patients compared with employed endometriosis participants.  166 
 Thus, our findings confirm that symptomatic, painful endometriosis can be a very disabling 167 
condition, to the point of preventing women from working. On the other hand, asymptomatic 168 
endometriosis (ie, pain-free, or with mild pain) seems to be compatible with a relatively ‘normal’ 169 
life, as also demonstrated by other studies on the psychological impact of the disease [3].  170 
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The role of chronic fatigue, which is another important symptom of endometriosis (although 171 
underinvestigated), should be clarified by future research, as well as the impact of sleep disorders, 172 
comorbidities, and surgical interventions. The fact that we did not investigate the effects of 173 
symptoms other than the main forms of pelvic pain, as well as the role of surgical and medical 174 
treatment, should be acknowledged as a limitation of our study.  175 
Moreover, although we controlled for the effects of several demographic variables, other 176 
factors such as women’s socioeconomic level, time after graduation, job availability in the area of 177 
study, length and type of employment, may influence employment status and thus moderate the 178 
impact of endometriosis on women’s professional life. Longitudinal and mixed-method studies 179 
including qualitative research techniques such as individual interviews and focus groups may allow 180 
a more in-depth and comprehensive exploration of the association between endometriosis, pelvic 181 
pain, and women’s working life (for instance, do pain symptoms affect women’s choices in terms of 182 
type of employment and time spent at work?).     183 
Our findings, although preliminary, may also provide ideas for future lines of inquiry by 184 
suggesting the importance of investigating the association between endometriosis-related symptoms 185 
and ‘soft’ work functioning outcomes, such as productivity, absenteeism/presenteeism, income, and 186 
job satisfaction. This avenue of investigation appears crucial, not only to assess women’s quality of 187 
life, but also to address political, economic, and social issues regarding the disabling nature of the 188 
disease.  189 
The importance of recognizing endometriosis as a social disease has been underlined in the 190 
scientific literature [8-17]. Reaching out to politicians is an important initial step to promote 191 
recognition of the social and economic burden of endometriosis [27]. In this regard, the role of 192 
patient associations is fundamental [28]. In Europe, several endometriosis support organizations 193 
approached the European Parliament to explain the multiple challenges entailed by living with the 194 
disease [27]. These initiatives led to the publication of a Written Declaration of Endometriosis (in 195 
March 2005) by a group of Members of the European Parliament [29]. An Italian patient association 196
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(Associazione Progetto Endometriosi—A.P.E. Onlus), together with EndoFrance (Association 197 
française de lutte contre l’endométriose), recently took part in the First Awareness Conference of 198 
Endometriosis at the European Parliament in Brussels (20th February 2018). The importance of a 199 
strategic collaboration between healthcare professionals (including psychologists/psychotherapists), 200 
researchers, patients, and legislators has already been highlighted by Bianconi et al. [27]. Research 201 
can provide all the instruments to develop evidence-based social policies and welfare programs to 202 
meet the needs of women with endometriosis. Specifically, community-based participatory research 203 
(CBPR), which equitably involves scientists and professionals, community members, and 204 
organizational representatives, may lead to multiple benefits, such as defining research topics that 205 
actually reflect major issues identified by the community, increasing trust between 206 
professionals/scientists and community, and facilitating the translation of research evidence into 207 
healthcare policies and practices [29,30]. Our study findings may help encourage this type of 208 
research.  209 
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Table 1 304 
Participant variables by study group. 305 
   Study Groups (N = 630) 
    Endometriosis subgroups (n = 298)  
 
 
Variable 
  Endometriosis 
(overall)  
(n = 298) 
Symptomatic 
endometriosis  
(n = 154) 
Asymptomatic 
endometriosis  
(n = 144) 
Control 
group 
(n = 332) 
Socio-
demographic  
 
Age [M, (SD)]  35.6 (5.4) 35.5 (5.2) 35.8 (5.5) 34.9 (5.9) 
Level of education  
[n, (%)] 
University 134 (45) 55 (36) 79 (55) 212 (64) 
High school 133 (45) 79 (51) 54 (37) 104 (31) 
Middle school 31 (10) 20 (13) 11 (8) 16 (5) 
Employed [n, (%)] Yes 257 (86) 123 (80) 134 (93) 311 (94) 
 No 41 (14) 31 (20) 10 (7) 21 (6) 
Marital status  
[n, (%)] 
Married 137 (46) 73 (47) 64 (44) 114 (34) 
Unmarried  161 (54) 81 (53) 80 (56) 218 (66) 
Pelvic pain 
[M, (SD)] 
Dysmenorrhea  
 
Employed  3.5 (3.5)    
Unemployed 4.8 (3.9)    
Dyspareunia  
 
Employed  2.7 (3.1)    
Unemployed 3.9 (3.5)    
Dyschezia  Employed  1.5 (2.6)    
Unemployed 2.7 (3.3)    
Chronic pelvic pain 
 
Employed  1.4 (2.6)    
Unemployed 2.6 (3.3)    
 306 
